To be practical for industrial use, biomarkers must be detectable using affordable and user-friendly techniques. Translating findings from untargeted, discovery analyses into simpler targeted assays, which require less expensive instrumentation, take less time, are more suitable for high-throughput analysis, and are required for regulatory compliance, will be key in accomplishing this.